Comprehensive Review of the Immunotherapy Drugs Market: Trends, Size, and Competitive Landscape
Market Overview Global Immunotherapy Drugs Market size and share is currently valued at USD 286.01 billion in 2024 and is anticipated to generate an estimated revenue of USD 1,152.03 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 15.0% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034 Immunotherapy drugs are biological agents used to stimulate or restore the immune system’s ability to detect and destroy harmful pathogens, malignant cells, or disease-causing organisms. Unlike chemotherapy or radiation, which directly target diseased cells, immunotherapy modulates the body’s natural defenses, making it an integral part of modern therapeutic strategies. The increasing prevalence of cancer, autoimmune diseases, and infectious diseases has spurred the demand for immunotherapy drugs. Advances in biotechnology, greater understanding of immune mechanisms, and breakthro...